Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06544473
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome - A Randomized Study
Sponsor: Aarhus University Hospital
Conditions
Estrogen Deficiency Estrogen Replacement Therapy Hormone Replacement Therapy Hypogonadism; Ovarian Turner Syndrome
Interventions
17-beta estradiol
Updated 1 time since 2024 Last updated: Aug 22, 2024 Started: Nov 29, 2021 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Estrogen Deficiency and Estrogen Replacement Therapy and is currently actively recruiting participants. Aarhus University Hospital leads this study, which shows 1 recorded version since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Aarhus University Hospital
- University of Aarhus
Data source: University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .